Andrew A. Moshfeghi
- Ophthalmology top 0.1%
- Retinal Diseases and Treatments 62
- Retinal and Optic Conditions 32
- Glaucoma and retinal disorders 26
- Intraocular Surgery and Lenses 21
- Ocular Diseases and Behçet’s Syndrome 18
- Ocular Infections and Treatments 13
-
- Retinal Imaging and Analysis 28
- Retinal and Macular Surgery 20
- Neurology top 10%
- Physiology top 10%
Andrew A. Moshfeghi
107 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Ophthalmology 2.9k
- Radiology, Nuclear Medicine and Imaging 1.9k
- Neurology 174
- Physiology 46
- Molecular Biology 567
Countries citing papers authored by Andrew A. Moshfeghi
This map shows the geographic impact of Andrew A. Moshfeghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew A. Moshfeghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew A. Moshfeghi more than expected).
Fields of papers citing papers by Andrew A. Moshfeghi
This network shows the impact of papers produced by Andrew A. Moshfeghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew A. Moshfeghi. The network helps show where Andrew A. Moshfeghi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew A. Moshfeghi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 13 | |
| 2 | Epidemiology of common retinal diseases in retina practices in the United States | 2020 | 1 |
| 3 | 2018 | 8 | |
| 4 | 2017 | 8 | |
| 5 | Quantitative spectral-domain optical coherence tomography angiography (OCTA) of Diabetic Retinopathy (DR) Severity | 2017 | 2 |
| 6 | Current Endophthalmitis Incidence Rates After Intravitreal Anti-VEGF Injections and Outcomes of Treatment | 2015 | 1 |
| 7 | 2015 | 49 | |
| 8 | 2015 | 136 | |
| 9 | 2015 | 28 | |
| 10 | 2015 | 95 | |
| 11 | 2013 | 22 | |
| 12 | 2013 | 4 | |
| 13 | 2012 | 10 | |
| 14 | Hypoxia And Increased VEGF Expression In Experimental Ocular Tuberculosis | 2012 | 1 |
| 15 | Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor Antagonists: A Six-Year Experience at a University Referral Center | 2011 | 7 |
| 16 | 2011 | 143 | |
| 17 | 2005 | 50 | |
| 18 | Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration (SANA) Study: Visual Acuity Outcomes | 2005 | 0 |
| 19 | Intravitreal Triamcinolone Acetonide Injection for Diabetic Macular Edema: Effect of Preparation Technique on Incidence of Anterior Chamber Reaction | 2003 | 3 |
| 20 | Lens-sparing Vitrectomy for Tractional Stage 4A Retinopathy of Prematurity Retinal Detachments | 2003 | 1 |
About Andrew A. Moshfeghi
Andrew A. Moshfeghi is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Physiology, having authored 111 papers that have together received 3.5k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (62 papers), Retinal and Optic Conditions (32 papers), Retinal Imaging and Analysis (28 papers), Glaucoma and retinal disorders (26 papers), Intraocular Surgery and Lenses (21 papers), Retinal and Macular Surgery (20 papers), Ocular Diseases and Behçet’s Syndrome (18 papers) and Ocular Infections and Treatments (13 papers). The work is most often cited by research in Ophthalmology (2.9k citations), Radiology, Nuclear Medicine and Imaging (1.9k citations) and Neurology (174 citations). Andrew A. Moshfeghi has collaborated with scholars based in United States, Mexico and Austria. Frequent co-authors include Philip J. Rosenfeld, Carmen A. Puliafito, Darius M. Moshfeghi, Harry W. Flynn, Kamyar Vaziri, Zohar Yehoshua, Renata Portella Nunes, Giovanni Gregori, William J. Feuer and Thomas A. Albini.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.